Novel drug regimen can improve stem cell transplantation outcomes – EurekAlert (press release)
|
Novel drug regimen can improve stem cell transplantation outcomes
EurekAlert (press release) NEW ORLEANS— Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers … |
